Oscar Health announced that Mario Schlosser will transition from his role as President of Technology and Chief Technology Officer to a new position as Co-Founder & Advisor to the CEO, effective June 1, 2026. The change is detailed in an amended and restated employment agreement. In his new advisory role, Schlosser will focus on the company's artificial intelligence and digital health initiatives and will continue to serve on the Board of Directors.
Key Details
- Role Transition: Mario Schlosser moves from President of Technology and CTO to Co-Founder & Advisor to the CEO, effective June 1, 2026.
- Compensation Changes: The amended agreement sets Schlosser's annual base salary at $370,000. He will no longer be eligible for an annual bonus (starting in 2026) or new long-term equity awards.
- Severance & Benefits: Schlosser is no longer entitled to cash severance or company-subsidized healthcare upon termination but will continue to vest in previously granted equity awards.